Regulation & Compliance

While California's cannabis market declined, MWG Holdings hit record revenues by focusing on community, innovation, and strategic growth. Here's how.

As schools adopt Copilot+ PCs and iOS, Saasyan's new update aims to provide seamless online safety monitoring across a diverse digital classroom.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

A new initiative highlights how wrongful death claims can offer financial relief to grieving families and address unpaid costs in the healthcare system.

At Access LIVE 2026, industry leaders tackled seismic shifts from RTDs and hemp regulations while celebrating innovation and collaborative leadership.

A major milestone in utility management signals a broader corporate shift toward centralized platforms for cost control, efficiency, and sustainability.

New AI assistants are automating tedious workforce tasks for front-line leaders, promising to free up time and combat rising labor costs and staff shortages.

A new initiative seeks to replace the tangled web of health data laws with a standardized, automated system for managing patient privacy and consent.

With transplant patient needs growing, BioMatrix promotes Heidi Ulbrich to manage its services, highlighting a model built for speed and complex care.

With single-use vapes banned, giants like The Vape Giant are launching advanced, high-puff kits. What does this mean for vapers, the market, and the law?

As the final call for Canada's premier journalism award arrives, a look at its legacy of impact and its vital role in a challenged media landscape.

In a strategic move, American Beacon Partners names a new product head to navigate a complex market and deliver next-generation solutions for financial advisors.

Discord is rolling out mandatory age verification globally. The move promises to protect teens but sparks user backlash over privacy and data security.

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Safe Harbor Financial secures a landmark deal with PCCU, boosting revenue by $9M but taking on more risk. A bold move in the evolving cannabis finance world.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

A Chinese biotech's novel nasal spray flu vaccine enters trials. Its unique design could finally make it safe for the elderly and expand global access.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.